Wheeler bio seals agreement with charles river to offer portable cmc® to discovery clients to accelerate their journey to first-in-human use

Wilmington, mass. and oklahoma city , feb. 29, 2024 /prnewswire/ -- wheeler bio, inc., an agile contract development and manufacturing organization (cdmo), announced today a new strategic agreement with charles river laboratories international, inc. (nyse: crl), a global leader in pharma services, to offer wheeler bio's portable cmc® (chemistry, manufacturing and controls) platform to charles river laboratory clients.
CRL Ratings Summary
CRL Quant Ranking